Vericel Corp

VCEL

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0000887359

SEC filings (opens in a new tab)

In the last 90 days, Vericel Corp insiders filed 0 open-market purchases and 7 sales; 323 institutions reported holding it in 13F filings for Q2 2026, worth $2.47B in total; no superinvestor holds it.

Key figures

Market capClose on Nov 13, 2026: $2.91B
Insider buysOpen market, last 90 days: 0
Insider sellsLast 90 days, $5.79M in total: 7
13F holdersQ2 2026, +43 vs. previous quarter: 323
13F valueReported value at the end of Q2 2026: $2.47B
Superinvestors holdingAt the end of Q2 2026: 0

Price chart

Chart by TradingView (opens in a new tab)

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2025: $276.3M; +16.5% year over year
Net income, FY2025: $16.5M; +59.4% year over year
Free cash flow, FY2025: $24.7M; No comparable prior period
Revenue, Q3 FY2026: $85.4M; +26.5% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest: 5.36M; Shares sold short
Change: +126.1K; +2.4% vs. previous
Days to cover: 9.83; At average daily volume

Superinvestors holding VCEL, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding VCEL at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Vericel Corp insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Nov 12, 2026 (view filing)8:04 PM ET	Nov 9-11	3 days	Mara Joseph Anthony JrChief Financial Officer	SSale	−25.0K	$58.26	−$1.46M	−60.7%16.2K after	2 lots10b5-1
Nov 12, 2026 (view filing)7:48 PM ET	Nov 10	2 days	McLaughlin Kevin FDirector	SSale	−7.00K	$58.96	−$412.7K	−27.7%18.3K after	10b5-1
Nov 12, 2026 (view filing)7:43 PM ET	Nov 9	3 days	Zerbe Robert L MDDirector	SSale	−2.00K	$57.88	−$115.8K	−5.7%33.0K after	10b5-1
Nov 9, 2026 (view filing)4:05 PM ET	Nov 5-6	4 days	Mara Joseph Anthony JrChief Financial Officer	SSale	−50.0K	$53.48	−$2.67M	−75.5%16.2K after	4 lots10b5-1
Nov 6, 2026 (view filing)4:05 PM ET	Nov 5	1 day	Siegal JonathanPrincipal Accounting Officer	SSale	−1.50K	$52.90	−$79.3K	−54.4%1.26K after	10b5-1
Nov 6, 2026 (view filing)4:05 PM ET	Nov 5	1 day	Flynn Sean C.Chief Legal Officer	SSale	−15.0K	$51.92	−$778.8K	−88.3%1.99K after	10b5-1
Nov 6, 2026 (view filing)4:05 PM ET	Nov 4-5	2 days	Zerbe Robert L MDDirector	SSale	−5.50K	$49.12	−$270.2K	−14.3%33.0K after	3 lots10b5-1
Aug 14, 2026 (view filing)4:05 PM ET	Aug 12	2 days	McLaughlin Kevin FDirector	SSale	−7.00K	$44.53	−$311.7K	−27.7%18.3K after	10b5-1
Aug 5, 2026 (view filing)4:05 PM ET	Aug 3	2 days	Halpin MichaelChief Operating Officer	SSale	−10.0K	$46.84	−$468.4K	−37.9%16.4K after	10b5-1
Jul 31, 2026 (view filing)4:05 PM ET	Jul 30	1 day	Siegal JonathanPrincipal Accounting Officer	SSale	−4.50K	$48.90	−$220.1K	−80.7%1.08K after	3 lots10b5-1

Top 10 13F holders, Q2 2026

See all 323 holders

The largest institutional positions in Vericel Corp at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding VCEL in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
BlackRock, Inc.	8,092,226	$360.0M	0.01%	+326,882+4.2%	Added
State Street Corp	3,293,975	$146.6M	0.00%	+141,845+4.5%	Added
Congress Asset Management Co	2,916,295	$129.7M	0.80%	+1,409,377+93.5%	Added
Vanguard Capital Management LLC	2,255,728	$100.4M	0.00%	+24,972+1.1%	Added
Conestoga Capital Advisors, LLC	2,083,832	$92.7M	2.02%	−379,480−15.4%	Reduced
William Blair Investment Management, LLC	1,992,855	$88.7M	0.27%	+160,146+8.7%	Added
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	1,639,988	$73.0M	0.07%	−83,584−4.8%	Reduced
GW&K Investment Management, LLC	1,550,497	$69.0M	0.54%	−66,358−4.1%	Reduced
Soleus Capital Management, L.P.	1,459,152	$64.9M	2.24%	−1,089,927−42.8%	Reduced
Geode Capital Management, LLC	1,341,244	$59.7M	0.00%	+86,382+6.9%	Added

Holders of 5% or more of VCEL

See all 3 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Vericel Corp.

Largest holders of VCEL from 13D and 13G filings
Holder	Latest form	Stake	Change	First filed	Latest filing	Filing
BlackRock, Inc.	13G/A	15.10%7.57M shares	–	Apr 30, 20251 filing	Apr 30, 2025	SEC
State Street Corp	13G	5.60%2.81M shares	–	Feb 10, 20225 filings	Nov 10, 2025	SEC
Vanguard Capital Management LLC	13G	5.11%2.60M shares	New	Apr 30, 20261 filing	Apr 30, 2026	SEC